Abstract
Objective. To perform a clinical and economic analysis in order to assess the beneits of antihypertensive and renal protective effects of the ixed combination perindopril arginine and indapamide in versus «traditional therapy» in hypertensive patients with renal insuficiency. Design and methods. We evaluated an indicator «costs-eficiency» by the cost of increase of glomerular iltration by 1 ml/hour (by Cockcroft-Gault formula, in each of group and decrease by 1 mg/l of proteinuria in both groups. Results and conclusions. Fixed combination of perindopril arginine/indapamide is economically beneicial according to the index «costs-eficiency» compared to traditional therapy.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
